201. Reactivation of human herpesvirus 6 (HHV-6) infection in patients with connective tissue diseases
- Author
-
Lisa Fusetti, Aurora Parodi, Mauro S. Malnati, Francesco Drago, Francesca Gatto, Stefania Paolino, Giulia Cassina, Luca Ceccherini-Nelli, B Matteoli, Paolo Lusso, Elisa Zaccaria, Francesco Broccolo, Broccolo, F, Drago, F, Paolino, S, Cassina, G, Gatto, F, Fusetti, L, Matteoli, B, Zaccaria, E, Parodi, A, Lusso, P, Ceccherini Nelli, L, and Malnati, M
- Subjects
Male ,Pathology ,Human herpesvirus 6 (HHV-6) ,Connective tissue diseases ,viruses ,Herpesvirus 6, Human ,Herpesvirus 7, Human ,Antibodies, Viral ,Polymerase Chain Reaction ,Scleroderma ,Pathogenesis ,80 and over ,Prevalence ,Viral load ,Viral ,Child ,Herpesviruses ,HHV-6 ,Real-time PCR ,Viral reactivation ,Adolescent ,Adult ,Aged ,Aged, 80 and over ,Autoimmune Diseases ,Connective Tissue Diseases ,Cross-Sectional Studies ,DNA, Viral ,Female ,Humans ,Middle Aged ,Roseolovirus Infections ,Viremia ,Young Adult ,Virus Activation ,Virology ,Infectious Diseases ,biology ,Medicine (all) ,Antibody titer ,virus diseases ,Connective tissue disease ,medicine.anatomical_structure ,Roseolovirus Infection ,Human herpesvirus 6 ,Antibody ,Human ,medicine.medical_specialty ,Connective tissue ,Peripheral blood mononuclear cell ,Autoimmune Disease ,Antibodies ,medicine ,Herpesvirus 6 ,Herpesvirus 7 ,Herpesviruse ,Connective Tissue Disease ,Cross-Sectional Studie ,DNA ,biochemical phenomena, metabolism, and nutrition ,medicine.disease ,biology.organism_classification ,Immunology ,biology.protein - Abstract
Background: Little is known about the involvement of human herpesviruses 6 and 7 (HHV-6 and HHV-7) in autoimmune connective tissue diseases (ACTD). Objective: To determine the prevalence of active infection with HHV-6 and HHV-7 in patients with ACTD. Study design: The presence and quantity of HHV-6 DNA was determined by quantitative real-time PCR in a cross-sectional study of serum, peripheral blood mononuclear cells, and tissues obtained from 58 ACTD patients and 38 healthy subjects (HS). Specific anti-HHV-6 antibody titer was also measured. Results: HHV-6 serum viremia occurred in a significantly higher proportion of ACTD patients compared to HS [26/58 (44.8%) vs. 1/38 (2.6%), p = 0.001] with the highest reactivation frequency [7/10 (70%)] observed in patients with scleroderma. Moreover, HHV-6 in serum was associated with ACTD activity (22/38 vs. 4/20, p < 0.05). Higher titers of HHV-6 antibodies were found in ACTD patients than in HS, although HHV-6 seroprevalence among patients with ACTD and HS was similar. HHV-7 viremia was not detected in any patients or HS controls. Conclusion: The frequent reactivation of HHV-6 in scleroderma and other ACTD, especially when active, suggests that HHV-6 may play a role in the pathogenesis of these diseases. © 2009 Elsevier B.V. All rights reserved
- Published
- 2009